David has been working in the pharmaceutical industry for over 40 years and has been involved in the analytical chemistry field and medicines testing facilities in various capacities. In 1990 he was awarded Qualified Person (QP) status. During his time with IQS and MTS he has been fully involved in Auditing International Manufacturing s
David has been working in the pharmaceutical industry for over 40 years and has been involved in the analytical chemistry field and medicines testing facilities in various capacities. In 1990 he was awarded Qualified Person (QP) status. During his time with IQS and MTS he has been fully involved in Auditing International Manufacturing sites, providing Analytical Method development and Quality Control Services. Whilst the Senior Director of CBF Associates, a pharmaceutical and biotechnology consulting company he has provided expert advice and support for Actavis, Teva, Cipla, Emcure and Select Pharma. David has an intimate knowledge of pharmaceutical Quality Management Systems, Technology Transfer, Batch release of sterile and non-sterile products as well as the EMA and MHRA regulatory systems. He qualified in 1986 from Napier College, Edinburgh with Royal Society of Chemistry 1 st Class and became a Fellow of the Society in 2016.
Neel Fofaria, PhD, is a Partner at MP Advisors/Mehta Partners, where he has led numerous strategic and investment advisory projects in BioPharma space at MP Advisors. He has been instrumental planning and execution of a range of marketing, manufacturing and R&D strategies. His responsibilities include generating high impact ideas, ident
Neel Fofaria, PhD, is a Partner at MP Advisors/Mehta Partners, where he has led numerous strategic and investment advisory projects in BioPharma space at MP Advisors. He has been instrumental planning and execution of a range of marketing, manufacturing and R&D strategies. His responsibilities include generating high impact ideas, identifying growth opportunities, and pitching it to the leading pharma and biotech companies worldwide for prospective mergers and alliances. At MP, Neel is spearheading a range of strategy engagements with companies ranging from pre-revenue start-ups to large pharma companies. He has extensive scientific and industry knowledge and over 12 years of experience in the BioPharma industry and medical device space. Neel brings in-depth knowledge of the Indian as well as global pharma markets with regards to the economic landscape, technological developments, industry-specific parameters, and the regulatory specifications. Before MP Advisors, Neel was a Life Sciences Consultant at LEK Consulting, one of the largest biopharma consulting firms in the world. During his role at LEK, Neel was involved with a range of engagements from large and small companies, from formulating and executing India marketing strategy to developing a niche product portfolio, to expanding R&D strategy, etc. Prior to his role at LEK Consulting, Neel was a scientist at Astra Zeneca, Waltham, MA.
During his role as a scientist at Astra Zeneca, Boston, USA, Neel led a multidisciplinary team involved in the preclinical development of an oncology molecule, which is now in clinical development. He has authored several articles in peer-reviewed journals and has 3 patents to his credit. Neel has also received several prestigious awards at various conferences such American Association for Cancer Research and the American Association of Pharmaceutical Scientists. Neel received his PhD in Pharmaceutical Sciences from Texas Tech University and a Bachelor of Pharmaceutical Sciences from the University of Mumbai.
Glen is a qualified Pharmacist with over 25 years’ experience in the pharmaceutical and healthcare sector, in a variety of technical, legal and commercial roles. He is named inventor on over 20 patents and his expertise covers the whole pathway of innovation through prosecution and enforcement/defence.
Before founding Savantium Ltd in Janu
Glen is a qualified Pharmacist with over 25 years’ experience in the pharmaceutical and healthcare sector, in a variety of technical, legal and commercial roles. He is named inventor on over 20 patents and his expertise covers the whole pathway of innovation through prosecution and enforcement/defence.
Before founding Savantium Ltd in January 2009, he was IP Manager at Vectura plc and previously Director of IP at Quadrant Drug Delivery Limited where he managed a portfolio of over 80 patent families and was instrumental in its expansion including over 50 US granted patents in 8 years. He studied Pharmacy at the University of Nottingham and completed his pre-registration training at Moorfield’s Eye Hospital, London, after working at Boots Healthcare International as a formulator.
Ms Ripple Mehta graduated in Pharmacy from the College of Pharmacy, Ahmedabad, India and has an MBA from North Gujarat University.
She brings extensive scientific and industry knowledge with more than fifteen years of experience in the pharmaceutical industry. She spent five years in the industry in the area of regulatory affairs, product
Ms Ripple Mehta graduated in Pharmacy from the College of Pharmacy, Ahmedabad, India and has an MBA from North Gujarat University.
She brings extensive scientific and industry knowledge with more than fifteen years of experience in the pharmaceutical industry. She spent five years in the industry in the area of regulatory affairs, product management and strategy planning. Ripple has worked in consulting for last ten years and has played pivotal roles in generating new business ideas for 10 plus project assignments covering NCE, Biosimilars, Generics and NDDS to crack product development/market/geographic challenges. She is an author of 10+plus therapy class reports which are bought by R & D houses of the Global US, Europe and Japanese large Cap & global generic companies. She has played an instrumental role in the numerous cross-border transactions that MP Advisors (Mehta Partners) has conceptualized during her tenure.
In Industry she worked at Claris Life sciences in their international regulatory department, and has worked with Dr Reddy’s and Astra Zeneca in Product Management. Ripple is based in Gujarat, India and regularly travels on business to Japan.
William graduated in Business Administration and Masters in Philosophy from University of Mining and Technology. William has spent over 17 years assisting foreign businesses from EU, Australia and US set up operations in China. Recently he was the senior Trade Officer for the Western Australian (WA) Trade Office.
During the last 6 years he
William graduated in Business Administration and Masters in Philosophy from University of Mining and Technology. William has spent over 17 years assisting foreign businesses from EU, Australia and US set up operations in China. Recently he was the senior Trade Officer for the Western Australian (WA) Trade Office.
During the last 6 years he was the Country Manager and Head of Operations for Stravencon Ltd. William has a comprehensive knowledge of the pharmaceutical and biotechnology industry in China as well as direct connections to the CFDA, Ministry of Commerce and Ministry of Health. William is currently a Director of DoubleWing Health & Beauty.
Byron is a pharmacist with an MBA. He is a Principal Consultant for ACE Consulting. Byron was General Manager of AstraZeneca Taiwan for 20 years and General Manager of Roche Diagnostics in China for five years.
For over 20 years Bryon represented the IFPMA and PhRMA in the area of Regulatory Affairs in Taiwan. He is currently a Director o
Byron is a pharmacist with an MBA. He is a Principal Consultant for ACE Consulting. Byron was General Manager of AstraZeneca Taiwan for 20 years and General Manager of Roche Diagnostics in China for five years.
For over 20 years Bryon represented the IFPMA and PhRMA in the area of Regulatory Affairs in Taiwan. He is currently a Director of a contact lens company and Chairman of Advagene Inc, a company developing therapeutic vaccines based in Taiwan.
Dr Mike Dyson has held a variety of executive positions in Life Science Companies in the USA and Europe. He specialises in Biopharma’s drug discovery and development, , in addition to Genomics and Diagnostic enterprises. Mike is a highly competent commercial individual, comfortable with working at all levels in all sectors; industrial, as
Dr Mike Dyson has held a variety of executive positions in Life Science Companies in the USA and Europe. He specialises in Biopharma’s drug discovery and development, , in addition to Genomics and Diagnostic enterprises. Mike is a highly competent commercial individual, comfortable with working at all levels in all sectors; industrial, as well as academic and governmental. . His professional background spans from sales and marketing management, product development and establishing new entities, to successfully driving International operations where the emphasis is on defining and opening new markets, creating venture capital interest and actual revenue streams.
With an understanding of several languages having lived and worked in the UK, Norway, Sweden, Germany and France, Mike has a well-developed sense of the different cultural drivers using them effectively to the business’ advantage. His focus is to support both early phase companies and more mature stage companies in need of a business turnaround, offering access to experience as assist during a particular phase or project and the opportunity to bring additional knowledge to the executive team through being a part or full time member.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data. Privacy Policy